Kiran Mazumdar-Shaw: India's Biotech Startups Need Follow-On Capital
Biocon's Kiran Mazumdar-Shaw tells SME Futures that Indian biotech startups lack growth-stage follow-on capital and clear exit paths for early investors.
Topic
Exits
Topic
Exits
Santa Fe VC Firm Lands Big Exits in Consumer Brands
A Santa Fe venture capital firm has scored major exits across its consumer-brand portfolio, the Albuquerque Journal reports — a r…
Defense Startup Funding Hits All-Time Record as VCs Eye Exits
Crunchbase News reports defense startup funding set an all-time record as venture capital firms in the sector begin to plan their…
Cooling IPO Market Delays Cash Payouts to Energy Investors
IPOs are set to cool, delaying cash flow distributions to limited partners as exits stall and energy sponsors weigh alternative r…
IPO Window Is Starting to Close, and VCs Are Watching
A Wall Street Journal report warns the IPO window is starting to close again, forcing venture investors to reassess exit timeline…
Forbes Asks Where The Chairs Are As Venture Capital Music Keeps Playing
Forbes argues venture capital remains active but the liquidity "chairs" have shifted. Full figures pending; the headline alone fr…
Helios Rings the Bell in Casablanca as African PE Exits Pick Up
Helios listed T2S Group in Casablanca at a $520 million valuation, while Eos Capital booked a 40% IRR — among five notable Africa…
Global Startup Funding Hits Record $510B in H1 2026
Global startup investment hit a record $510 billion in H1 2026, Crunchbase data shows, as the AI boom accelerated both venture fu…